Universal Health (UHS) Tops Q4 EPS by 8c, Guidance Tops Consensus

Universal Health (NYSE: UHS) reported Q4 EPS of $2.95, $0.08 better than the analyst estimate of $2.87. Revenue for the quarter came in at $3.28 billion versus the consensus estimate of $3.14 billion.

GUIDANCE:

Universal Health sees FY2022 EPS of $11.90-$12.90, versus the consensus of $12.24. Universal Health sees FY2022 revenue of $13.424-13.694 billion, versus the consensus of $12.88 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Creatd files Form S-1 and reports Q1 2026 financial results
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight